Motley Fool Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$223K	Buy	3,952 +565	+17%	+$32.9K	0.01%	232
2025 Q4	$201K	Sell	3,387 -28,632	-89%	-$1.56M	0.01%	238
2025 Q3	$1.73M	Sell	32,019 -33,016	-51%	-$1.89M	0.07%	159
2025 Q2	$3.57M	Buy	65,035 +51,682	+387%	+$3.04M	0.16%	111
2025 Q1	$944K	Buy	13,353 +41	+0.3%	+$2.76K	0.05%	161
2024 Q4	$875K	Sell	13,312 -135,486	-91%	-$9.08M	0.05%	160
2024 Q3	$10.4M	Sell	148,798 -1,941	-1%	-$162K	0.62%	41
2024 Q2	$12.4M	Buy	150,739 +103,824	+221%	+$8.64M	0.82%	29
2024 Q1	$4.1M	Buy	46,915 +2,792	+6%	+$250K	0.27%	81
2023 Q4	$4.25M	Sell	44,123 -1,238	-3%	-$110K	0.32%	74
2023 Q3	$4.01M	Buy	45,361 +41,929	+1,222%	+$3.73M	0.32%	70
2023 Q2	$297K	Buy	+3,432	New	+$323K	0.03%	188
2023 Q1	–	Sell	-3,369	Closed	-$349K	–	122
2022 Q4	$349K	Sell	3,369 -271	-7%	-$25.4K	0.04%	178
2022 Q3	$309K	Sell	3,640 -84	-2%	-$7.48K	0.03%	187
2022 Q2	$322K	Buy	3,724 +13	+0.4%	+$1.03K	0.03%	189
2022 Q1	$286K	Buy	3,711 +3,625	+4,215%	+$303K	0.02%	198
2021 Q4	$8K	Buy	+86	New	+$7.1K	﹤0.01%	195
2020 Q3	–	Sell	-3,172	Closed	-$391K	–	165
2020 Q2	$391K	Buy	3,172 +120	+4%	+$11.9K	0.04%	154
2020 Q1	$258K	Buy	+3,052	New	+$263K	0.03%	158
2019 Q2	–	Sell	-2,827	Closed	-$251K	–	170
2019 Q1	$251K	Buy	+2,827	New	+$262K	0.03%	160
2018 Q4	–	Sell	-2,233	Closed	-$217K	–	161
2018 Q3	$217K	Buy	+2,233	New	+$223K	0.03%	146